Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial.
Wadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT; STEP 3 Investigators. Wadden TA, et al. Among authors: wallenstein sor. JAMA. 2021 Apr 13;325(14):1403-1413. doi: 10.1001/jama.2021.1831. JAMA. 2021. PMID: 33625476 Free PMC article. Clinical Trial.
Cancer in General Responders Participating in World Trade Center Health Programs, 2003-2013.
Shapiro MZ, Wallenstein SR, Dasaro CR, Lucchini RG, Sacks HS, Teitelbaum SL, Thanik ES, Crane MA, Harrison DJ, Luft BJ, Moline JM, Udasin IG, Todd AC. Shapiro MZ, et al. Among authors: wallenstein sr. JNCI Cancer Spectr. 2019 Nov 6;4(1):pkz090. doi: 10.1093/jncics/pkz090. eCollection 2020 Feb. JNCI Cancer Spectr. 2019. PMID: 32337498 Free PMC article.
Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial.
Pieber TR, Bode B, Mertens A, Cho YM, Christiansen E, Hertz CL, Wallenstein SOR, Buse JB; PIONEER 7 investigators. Pieber TR, et al. Among authors: wallenstein sor. Lancet Diabetes Endocrinol. 2019 Jul;7(7):528-539. doi: 10.1016/S2213-8587(19)30194-9. Epub 2019 Jun 9. Lancet Diabetes Endocrinol. 2019. PMID: 31189520 Clinical Trial.
Response to Soskolne [2017].
Boffetta P, Zeig-Owens R, Wallenstein S, Li J, Brackbill RM, Cone J, Farfel M, Holden W, Lucchini R, Webber MP, Prezant D, Stellman SD, Hall CB. Boffetta P, et al. Among authors: wallenstein s. Am J Ind Med. 2017 May;60(5):512. doi: 10.1002/ajim.22713. Am J Ind Med. 2017. PMID: 28409859 No abstract available.
The association between body mass index and gastroesophageal reflux disease in the World Trade Center Health Program General Responder Cohort.
Icitovic N, Onyebeke LC, Wallenstein S, Dasaro CR, Harrison D, Jiang J, Kaplan JR, Lucchini RG, Luft BJ, Moline JM, Pendem L, Shapiro M, Udasin IG, Todd AC, Teitelbaum SL. Icitovic N, et al. Among authors: wallenstein s. Am J Ind Med. 2016 Sep;59(9):761-6. doi: 10.1002/ajim.22637. Am J Ind Med. 2016. PMID: 27582478
173 results